1. Japanese Clinical Practice Guideline for Diabetes 2019

   • Eiichi Araki
   • Atsushi Goto
   • Narihito Yoshioka

   Guideline 24 July 2020 Pages: 165 - 223

   

2. Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling

   • Toshimasa Yamauchi
   • Hideki Kamiya
   • Tatsuya Kondo

   Consensus Report 25 July 2020 Pages: 224 - 239

   

3. Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic

   • Shota Suzuki
   • Yukie Ito
   • Masato Kasahara

   Commentary 19 June 2020 Pages: 240 - 241

4. Current understanding of the effect of sodium–glucose co-transporter-2 inhibitors in Asian patients with diabetes mellitus

   • Hirotaka Watada

   Introduction to Mini-Reviews 08 June 2020 Pages: 242 - 244

5. Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches

   • Munehiro Kitada
   • Taro Hirai
   • Daisuke Koya

   Mini-Review 11 June 2020 Pages: 245 - 251

6. Promising roles of sodium–glucose cotransporter 2 inhibitors in heart failure prevention and treatment

   • Atsushi Tanaka
   • Koichi Node

   Mini-Review 11 June 2020 Pages: 252 - 260

   

7. Work-related, personal, and diabetes-related factors relevant to dropout from outpatient diabetes treatment visits among Japanese male employees with diabetes

   • Nao Sonoda
   • Soichiro Watanabe
   • Akiko Morimoto

   Original Article 16 December 2019 Pages: 261 - 268

   

8. Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance

   • Shigeru Inoue
   • Yutaka Kozuma
   • Kimio Ushijima

   Original Article 08 February 2020 Pages: 269 - 273

   

9. Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)

   • Yuichi Terawaki
   • Chikayo Iwaya
   • Collaborators in the Repaglinide Glucose Oscillation Study in Fukuoka (REGO-F) trial

   Original Article 14 February 2020 Pages: 274 - 282

   

10. Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study

    • Serdar Kaymaz
    • Hakan Alkan
    • Veli Çobankara

    Original Article 21 February 2020 Pages: 283 - 292

    

11. Plasma lipopolysaccharide binding protein level statistically mediates between body mass index and chronic microinflammation in Japanese patients with type 1 diabetes

    • Hirotaka Watanabe
    • Takashi Katsura
    • Iichiro Shimomura

    Short Communication 09 March 2020 Pages: 293 - 297